Lisa Palermo

15.9k total citations · 5 hit papers
86 papers, 11.6k citations indexed

About

Lisa Palermo is a scholar working on Orthopedics and Sports Medicine, Surgery and Oncology. According to data from OpenAlex, Lisa Palermo has authored 86 papers receiving a total of 11.6k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Orthopedics and Sports Medicine, 35 papers in Surgery and 31 papers in Oncology. Recurrent topics in Lisa Palermo's work include Bone health and osteoporosis research (73 papers), Bone health and treatments (31 papers) and Bone and Joint Diseases (24 papers). Lisa Palermo is often cited by papers focused on Bone health and osteoporosis research (73 papers), Bone health and treatments (31 papers) and Bone and Joint Diseases (24 papers). Lisa Palermo collaborates with scholars based in United States, United Kingdom and Italy. Lisa Palermo's co-authors include Dennis M. Black, Steven R. Cummings, Kristine E. Ensrud, Harry K. Genant, Michael C. Nevitt, Jane A. Cauley, Douglas C. Bauer, Ann V. Schwartz, John P. Bilezikian and Clifford J. Rosen and has published in prestigious journals such as New England Journal of Medicine, JAMA and American Journal of Clinical Nutrition.

In The Last Decade

Lisa Palermo

86 papers receiving 11.2k citations

Hit Papers

Effects of Continuing or Stopping Alendronate After ... 1993 2026 2004 2015 2006 2003 1999 1993 1996 250 500 750 1000

Peers

Lisa Palermo
Richard D. Wasnich United States
Arthur C. Santora United States
Cesar Libanati United States
H. W. Minne Germany
Charles H. Chesnut United States
J. A. Kanis United Kingdom
S. Adámi Italy
Richard D. Wasnich United States
Lisa Palermo
Citations per year, relative to Lisa Palermo Lisa Palermo (= 1×) peers Richard D. Wasnich

Countries citing papers authored by Lisa Palermo

Since Specialization
Citations

This map shows the geographic impact of Lisa Palermo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Palermo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Palermo more than expected).

Fields of papers citing papers by Lisa Palermo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Palermo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Palermo. The network helps show where Lisa Palermo may publish in the future.

Co-authorship network of co-authors of Lisa Palermo

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Palermo. A scholar is included among the top collaborators of Lisa Palermo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Palermo. Lisa Palermo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Margolis, Karen L., Lisa Palermo, Eric Vittinghoff, et al.. (2014). Intensive Blood Pressure Control, Falls, and Fractures in Patients with Type 2 Diabetes: The ACCORD Trial. Journal of General Internal Medicine. 29(12). 1599–1606. 53 indexed citations
2.
Cosman, Felicia, Jane A. Cauley, Richard Eastell, et al.. (2014). Reassessment of Fracture Risk in Women After 3 Years of Treatment With Zoledronic Acid: When is it Reasonable to Discontinue Treatment?. The Journal of Clinical Endocrinology & Metabolism. 99(12). 4546–4554. 83 indexed citations
3.
Eastell, Richard, Dennis M. Black, Steven Boonen, et al.. (2010). Effect of Once-Yearly Zoledronic Acid Five Milligrams on Fracture Risk and Change in Femoral Neck Bone Mineral Density. Obstetrical & Gynecological Survey. 65(3). 177–178. 12 indexed citations
4.
Cauley, Jane A., Dennis M. Black, Steven Boonen, et al.. (2010). Once-yearly zoledronic acid and days of disability, bed rest, and back pain: Randomized, controlled HORIZON Pivotal Fracture Trial. Journal of Bone and Mineral Research. 26(5). 984–992. 26 indexed citations
5.
Black, Dennis M., Michael P. Kelly, Harry K. Genant, et al.. (2010). Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur. New England Journal of Medicine. 362(19). 1761–1771. 373 indexed citations
6.
Schwartz, Ann V., Douglas C. Bauer, Steven R. Cummings, et al.. (2010). Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: The FLEX Trial. Journal of Bone and Mineral Research. 25(5). 976–982. 202 indexed citations
7.
Donaldson, Meghan G, Lisa Palermo, John T. Schousboe, et al.. (2009). FRAX and Risk of Vertebral Fractures: The Fracture Intervention Trial. Journal of Bone and Mineral Research. 24(11). 1793–1799. 76 indexed citations
8.
Black, Dennis M., Mary Bouxsein, Lisa Palermo, et al.. (2008). Randomized Trial of Once-Weekly Parathyroid Hormone (1-84) on Bone Mineral Density and Remodeling. The Journal of Clinical Endocrinology & Metabolism. 93(6). 2166–2172. 40 indexed citations
9.
Clark, Patricia, Fidencio Cons-Molina, Margarita Delezé, et al.. (2008). The prevalence of radiographic vertebral fractures in Latin American countries: the Latin American Vertebral Osteoporosis Study (LAVOS). Osteoporosis International. 20(2). 275–282. 126 indexed citations
10.
Black, Dennis M., Ann V. Schwartz, Kristine E. Ensrud, et al.. (2007). Effects of Continuing or Stopping Alendronate After 5 Years of Treatment. The Fracture Intervention Trial Long-term Extension (FLEX): A Randomized Trial. Obstetrical & Gynecological Survey. 62(4). 251–252. 60 indexed citations
11.
Cauley, Jane A., Marc C. Hochberg, Li‐Yung Lui, et al.. (2007). Long-term Risk of Incident Vertebral Fractures. JAMA. 298(23). 2761–2761. 185 indexed citations
12.
Bauer, Douglas C., Patrick Garnero, John P. Bilezikian, et al.. (2006). Short-Term Changes in Bone Turnover Markers and Bone Mineral Density Response to Parathyroid Hormone in Postmenopausal Women with Osteoporosis. The Journal of Clinical Endocrinology & Metabolism. 91(4). 1370–1375. 94 indexed citations
13.
14.
Black, Dennis M., John P. Bilezikian, Kristine E. Ensrud, et al.. (2005). One Year of Alendronate After One Year of Parathyroid Hormone (1???84) for Osteoporosis. Obstetrical & Gynecological Survey. 61(1). 34–35. 52 indexed citations
15.
Black, Dennis M., John P. Bilezikian, Kristine E. Ensrud, et al.. (2005). One Year of Alendronate after One Year of Parathyroid Hormone (1–84) for Osteoporosis. New England Journal of Medicine. 353(6). 555–565. 424 indexed citations
16.
Lane, Nancy E., Michael C. Nevitt, Marc C. Hochberg, Yun‐Yi Hung, & Lisa Palermo. (2004). Progression of radiographic hip osteoarthritis over eight years in a community sample of elderly white women. Arthritis & Rheumatism. 50(5). 1477–1486. 91 indexed citations
17.
Vogt, Molly T., David A. Rubin, Lisa Palermo, et al.. (2003). Lumbar spine listhesis in older African American women. The Spine Journal. 3(4). 255–261. 52 indexed citations
18.
Black, Dennis M., M. Steinbuch, Lisa Palermo, et al.. (2001). An Assessment Tool for Predicting Fracture Risk in Postmenopausal Women. Osteoporosis International. 12(7). 519–528. 374 indexed citations
20.
Cummings, Steven R., Jane A. Cauley, Lisa Palermo, et al.. (1994). Racial differences in hip axis lengths might explain racial differences in rates of hip fracture. Osteoporosis International. 4(4). 226–229. 243 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026